Page last updated: 2024-09-04

3,3',4'-trihydroxyflavone and succinic acid

3,3',4'-trihydroxyflavone has been researched along with succinic acid in 1 studies

Compound Research Comparison

Studies
(3,3',4'-trihydroxyflavone)
Trials
(3,3',4'-trihydroxyflavone)
Recent Studies (post-2010)
(3,3',4'-trihydroxyflavone)
Studies
(succinic acid)
Trials
(succinic acid)
Recent Studies (post-2010) (succinic acid)
390224,219291,672

Protein Interaction Comparison

ProteinTaxonomy3,3',4'-trihydroxyflavone (IC50)succinic acid (IC50)
Solute carrier family 13 member 3Homo sapiens (human)107
Egl nine homolog 1Homo sapiens (human)3

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Berdeaux, A; Eychenne, N; Long, R; Morin, D; Pons, S; Woodman, OL1

Other Studies

1 other study(ies) available for 3,3',4'-trihydroxyflavone and succinic acid

ArticleYear
The cardioprotectant 3',4'-dihydroxyflavonol inhibits opening of the mitochondrial permeability transition pore after myocardial ischemia and reperfusion in rats.
    Pharmacological research, 2014, Volume: 81

    Topics: Animals; Cardiotonic Agents; Flavonols; Malates; Male; Mitochondria, Heart; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Myocardial Reperfusion Injury; Oxygen Consumption; Pyruvic Acid; Rats, Wistar; Reactive Oxygen Species; Rotenone; Succinic Acid

2014